NCT05701007 2026-01-29
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Completed
Clinical Trials
11 trialsNCT07344779 2026-01-26
ROAD
Bayer
Not yet recruiting
NCT04034095 2025-12-15
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
Janssen Pharmaceutical K.K.
Completed
NCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT03328364 2024-11-21
A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden
Astellas Pharma Inc
Completed
NCT06498921 2024-10-24
BELBEQA
Bayer
Completed
NCT02376296 2022-02-17
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
Saladax Biomedical, Inc.
Completed
NCT03419442 2020-10-22
Multi-academic Center Study of Xofigo Patients
Bayer
Completed
NCT02479217 2017-02-17
Safety of Xeloda in Solid Tumours
Hoffmann-La Roche
Completed
NCT01777945 2016-08-19
XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer
Hoffmann-La Roche
Completed
NCT00452985 2012-08-14
OCSTUD
Sanofi
Completed